BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35954195)

  • 1. Immunorthodontics: PD-L1, a Novel Immunomodulator in Cementoblasts, Is Regulated by HIF-1α under Hypoxia.
    Yong J; Gröger S; von Bremen J; Meyle J; Ruf S
    Cells; 2022 Jul; 11(15):. PubMed ID: 35954195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunorthodontics: Role of HIF-1α in the Regulation of (Peptidoglycan-Induced) PD-L1 Expression in Cementoblasts under Compressive Force.
    Yong J; Gröger S; Meyle J; Ruf S
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor 1-alpha acts as a bridge factor for crosstalk between ERK1/2 and caspases in hypoxia-induced apoptosis of cementoblasts.
    Yong J; von Bremen J; Groeger S; Ruiz-Heiland G; Ruf S
    J Cell Mol Med; 2021 Oct; 25(20):9710-9723. PubMed ID: 34523215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1, a Potential Immunomodulator Linking Immunology and Orthodontically Induced Inflammatory Root Resorption (OIIRR): Friend or Foe?
    Yong J; Gröger S; von Bremen J; Meyle J; Ruf S
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HUVECs affect HuT-78 cell apoptosis and cytokine production via the HIF-1α-PD-L1/PD-1 pathway under hypoxia.
    Qiang L; Hong L; Jian X; Zhanlin Z
    Int Immunopharmacol; 2023 May; 118():110010. PubMed ID: 36924563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo.
    Xu H; Chen Y; Li Z; Zhang H; Liu J; Han J
    Eur J Pharmacol; 2022 Sep; 930():175154. PubMed ID: 35868447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
    Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
    Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
    Noman MZ; Desantis G; Janji B; Hasmim M; Karray S; Dessen P; Bronte V; Chouaib S
    J Exp Med; 2014 May; 211(5):781-90. PubMed ID: 24778419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of programmed death-ligand 1 and hypoxia-inducible factor-1α proteins in endometrial carcinoma.
    Tawadros AIF; Khalafalla MMM
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1063-S1069. PubMed ID: 30539847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway.
    Tian X; Liu F; Wang Z; Zhang J; Liu Q; Zhang Y; Zhang D; Huang C; Zhao J; Jiang S
    J Ethnopharmacol; 2024 Mar; 322():117577. PubMed ID: 38104877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tumor Microenvironment Mediates the HIF-1α/PD-L1 Pathway to Promote Immune Escape in Colorectal Cancer.
    Sun J; Zhao Z; Lu J; An W; Zhang Y; Li W; Yang L
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Artery Embolization Enhances Expression of Programmed Cell Death 1 Ligand 1 in an Orthotopic Rat Hepatocellular Carcinoma Model: In Vivo and in Vitro Experimentation.
    Takaki H; Hirata Y; Ueshima E; Kodama H; Matsumoto S; Wada R; Suzuki H; Nakasho K; Yamakado K
    J Vasc Interv Radiol; 2020 Sep; 31(9):1475-1482.e2. PubMed ID: 32800663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
    Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
    Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia.
    Ding XC; Wang LL; Zhang XD; Xu JL; Li PF; Liang H; Zhang XB; Xie L; Zhou ZH; Yang J; Weichselbaum RR; Yu JM; Hu M
    J Hematol Oncol; 2021 Jun; 14(1):92. PubMed ID: 34118979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 Regulates Inflammation in LPS-Induced Lung Epithelial Cells and Vascular Endothelial Cells by Interacting with the HIF-1α Signaling Pathway.
    Zhao S; Gao J; Li J; Wang S; Yuan C; Liu Q
    Inflammation; 2021 Oct; 44(5):1969-1981. PubMed ID: 34014492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
    Chang YL; Yang CY; Lin MW; Wu CT; Yang PC
    Eur J Cancer; 2016 Jun; 60():125-35. PubMed ID: 27107327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages.
    Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X
    Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of HIF-1α/PD-L1 by Catalytic Topoisomerase Inhibitor Induces Cell Death Through Caspase Activation in Cancer Cells Under Hypoxia.
    Miyata S; Ishii T; Kitanaka S
    Anticancer Res; 2024 Jan; 44(1):49-59. PubMed ID: 38159998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
    Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
    World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
    Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
    J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.